What Does ‘Off-Label’ Mean in Cosmetic Treatments?

The term “off-label” “comes up frequently in conversations about cosmetic treatments, from neurotoxins like Botox Cosmetic to hyaluronic acid fillers like Restylane and Skinvive. It might sound elusive, even a little questionable, but the reality is that it’s extremely common medical jargon for a totally standard, and legal, practice.

Ahead, we’re diving deeper into the off-label basics, real-world examples and the questions worth asking before you say yes.

Featured Experts

• Jacob Beer, MD is a board-certified dermatologist in West Palm Beach, FL
• Kristina Collins, MD is a board-certified dermatologist in Austin, TX

What Does ‘Off-Label’ Actually Mean?

In the simplest terms, off-label use means a treatment is being used for something other than what the FDA originally approved it for. That could mean a filler approved for one area of the face being injected somewhere else entirely, or a neurotoxin being used for a concern it hasn’t officially been cleared to treat yet.

The Most Common Off-Label Uses in Cosmetic Dermatology

If you’ve had Botox (or any brand of neurotoxin) for anything beyond forehead lines or crow’s feet, there’s a good chance you’ve already had an off-label treatment. “Some of the most common off-label uses I perform involve Botox for jawline slimming, treatment of the platysmal neck bands, lip flips, correction of a gummy smile and subtle lifting of the nasal tip,” says Austin dermatologist Kristina Collins, MD. “With fillers, we frequently use hyaluronic acid products to improve the temples, jawline, chin, hands and even to camouflage certain scars.”

Not every neurotoxin is approved for the same areas, adds West Palm Beach dermatologist Jacob Beer, MD. “Almost all of the neuromodulators are FDA approved for the glabellar [elevens],” he says. “However, certain neuromodulators such as Daxxify and Dysport are not FDA approved for lateral canthal lines [crow’s feet]. Many practitioners still use those products for treatment of crow’s feet; however, there they are used off-label until they get FDA approval for that specific indication.”

So how do these off-label treatments earn that trust? According to Dr. Collins, it’s not overnight. “These treatments became widely accepted because experienced injectors consistently observed positive outcomes in clinical practice, and those observations were supported over time by published studies, expert consensus and advances in injection techniques,” she says. “In aesthetics, innovation often begins with physicians carefully applying an existing treatment in new ways while prioritizing patient safety.”

Can an Off-Label Treatment Eventually Become FDA-Approved?

Yes, off-label treatments can eventually become FDA-approved, but “only after the manufacturer chooses to pursue that indication by conducting rigorous clinical trials demonstrating safety and effectiveness for the new treatment area,” Dr. Collins explains. “The process requires substantial scientific evidence and regulatory review, so many off-label uses remain off-label simply because obtaining an additional indication is expensive and time-consuming, not because the treatment lacks merit.”

Botox is a prime example. “It was initially approved for relatively few cosmetic indications but has since gained FDA approval for additional areas such as crow’s feet and forehead lines after strong clinical data supported its use,” Dr. Collins adds.

Dr. Beer, who runs clinical trials in his own practice, has seen this play out firsthand with injectables that are now household names. “Recently, Skinvive gained FDA approval [for] horizontal neck lines. It initially was FDA approved for skin smoothness of the cheeks in 2023,” he says. “Similarly, Restylane Contour was initially used for temples off-label until March 2026, when it was FDA-approved for temples.”

What to Ask Before Getting an Off-Label Treatment

Off-label doesn’t automatically mean risky, but it does mean you should come prepared with the right questions. “Patients should ask how frequently their provider performs that specific off-label procedure, what the evidence is supporting its use and whether the injector has before-and-after photos of patients treated for the same concern,” says Dr. Collins. She also recommends asking why a treatment is off-label in the first place: “Is it because the FDA hasn’t reviewed that specific indication yet, or because it’s a newer technique with more limited evidence?”

Beyond that, she suggests asking what product is being used, what alternatives exist, how long results typically last and what the plan is if the outcome isn’t what you hoped for. “The success of any injectable treatment depends far more on the expertise of the injector than whether the indication itself is technically on- or off-label,” she says. All of this to say, off-label or not, trust the hands, not just the label.